홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

2,2-Dimethyl-3-oxazolidinecarboxylate → HCID 178513886, 화합물

HRID 654885
인쇄

반응식

HRID 654885 반응식
CC1(C)[N:6](C([O-])=O)CCO1.C(S(C[C@@H](CC1C=CC=CC=1)C(N[C@H:23]([C:42]([OH:44])=O)[CH2:24][C:25]1[N:29](C2C=CC([N+]([O-])=O)=CC=2[N+]([O-])=O)[CH:28]=[N:27][CH:26]=1)=O)(=O)=O)(C)(C)C>>[NH:27]1[CH:26]=[C:25]([CH2:24][CH2:23][C:42]([NH2:6])=[O:44])[N:29]=[CH:28]1
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

3

반응물 2

HCID 190810462,2-Dimethyl-3-oxazolidinecarboxylateHCID 22845096N-[(S)-alpha-[(t-butylsulphonyl)methyl]hydrocinnamoyl]-3-(2,4-dinitrophenyl)-L-histidine

생성물 1

HCID 178513886HCID 178513886, 화합물

실험 절차

In an analogous manner to that described in Example 16, by reacting t-butyl (4S,5R)-4-(cyclohexylmethyl)-5-[(R or S)-hydroxy-[(R or S)-tetrahydro-2-furyl]-methyl]-2,2-dimethyl-3-oxazolidinecarboxylate with N-[(S)-α-[(t-butylsulphonyl)methyl]hydrocinnamoyl]-3-(2,4-dinitrophenyl)-L-histidine there is obtained (S)-α-[(S)-α-[(t-butylsulphonyl)methyl]hydrocinnamamido]-N-[(1S,2R,3R or S)-1-(cyclohexylmethyl)-2,3-dihydroxy-3[(R or S)-tetrahydro-2-furyl]propyl]imidazole-4-propionamide in the form of a yellow amorphous powder, MS: 827 (M+H)+. The cleavage of the dinitrophenyl group with thiolactic acid is effected in an analogous manner to Example 13 and yields (S)-α-[(S)-α-[(t-butylsulphonyl)methyl]hydrocinnamamido]-N-[(1S,2R,3R or S)-1-(cyclohexylmethyl -2,3-dihydroxy-3-[(R or S)-tetrahydro-2-furyl]propyl]imidazole-4-propionamide as a pale yellow amorphous solid, MS: 661 (M+H)+.

출처 및 근거

ORD 기록
ord-8a31e2342466419db5f6d17f8889ed29
출처 데이터셋
uspto-grants-1992_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05134123

반응 노트

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트